Previous Close | 2.0800 |
Open | 2.0600 |
Bid | 2.0600 x 0 |
Ask | 2.1200 x 0 |
Day's Range | 2.0600 - 2.1100 |
52 Week Range | 0.9600 - 2.4000 |
Volume | |
Avg. Volume | 13,635 |
Market Cap | 52.053M |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1200 |
Earnings Date | Aug 14, 2024 - Aug 19, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Covalon Technologies ( CVE:COV ) Second Quarter 2024 Results Key Financial Results Revenue: CA$8.41m (up 16% from 2Q...
MISSISSAUGA, Ontario, May 29, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.
MISSISSAUGA, Ontario, May 22, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 29, 2024, at 8:15am ET.